Edrophonium Chloride

依酚氯铵

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameEdrophonium Chloride
Drug Alias Namecloruro de edrofonio氯化腾喜龙氯化滕西隆edrophonii chloridumTensilon +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsMuscle relaxation antagonists
TargetsAcetylcholinesterase
Therapy Area/IndicationsMyasthenia Gravis
Global Approved IndicationsMyasthenia Gravis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1951/05/03
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTeligent
China Registration ClassN/A

Develop Information

Active CompaniesKyorin Pharmaceutical Co LtdJinan Bosch Pharmaceutical Technology Co Ltd
Inactive CompaniesPharmaceutical Associates Inc
Active IndicationsMyasthenia Gravis
Inactive IndicationsN/A

Other Information

ATC CodeV04CX
Related LinksWikipediaDrugBankKEGG